OTC Markets EXMKT - Delayed Quote USD
Matricelf Ltd (MTRLF)
1.9000
0.0000
(0.00%)
As of June 5 at 8:00:00 PM EDT. Market Open.
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Gil Hakim | Chief Executive Officer | 769.01k | -- | 1969 |
| Mr. Alon Sinai | Co-Founder, Deputy CEO, President & Director | 1.28M | -- | 1967 |
| Prof. Tal Dvir Ph.D. | Co-Founder, Chief Scientist & Director | 300k | -- | 1974 |
| Ms. Sigal Russo-Gueta | VP of Finance & CFO | 645k | -- | 1978 |
| Ms. Tamar Harel Adar Ph.D. | Vice President of Research & Development | 612k | -- | 1978 |
| Tal Ben Neriah | Vice President of Operations | -- | -- | 1983 |
Matricelf Ltd
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 12
Description
Matricelf Ltd, a biotechnology company, develops a platform for autologous tissue engineering for various medical conditions. The company's regenerative medicine platform intends to cure a range of medical conditions, including spinal cord injuries, age-related macular degeneration, Parkinson's disease, and myocardial infarction, as well as for 3D bioprinting. Matricelf Ltd was incorporated in 2019 and is based in Ness Ziona, Israel.
Corporate Governance
Matricelf Ltd’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available